Biogen Inc
NASDAQ:BIIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biogen Inc
NASDAQ:BIIB
|
US |
|
V
|
Vow ASA
OSE:VOW
|
NO |
|
Hangzhou Freely Communication Co Ltd
SSE:603602
|
CN |
|
Soho Global Health Tbk PT
IDX:SOHO
|
ID |
|
Nickel Creek Platinum Corp
TSX:NCP
|
CA |
|
Asian Healthcare Specialists Ltd
SGX:1J3
|
SG |
|
LG Innotek Co Ltd
KRX:011070
|
KR |
|
S
|
Silicon 2 Co Ltd
KOSDAQ:257720
|
KR |
|
S
|
Sewoo Global Co Ltd
KRX:013000
|
KR |
|
CardioGenics Holdings Inc
OTC:CGNH
|
US |
Wall Street
Price Targets
BIIB Price Targets Summary
Biogen Inc
According to Wall Street analysts, the average 1-year price target for
BIIB
is 210.62 USD
with a low forecast of 151.5 USD and a high forecast of 273 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BIIB's stock price target?
Price Target
210.62
USD
According to Wall Street analysts, the average 1-year price target for
BIIB
is 210.62 USD
with a low forecast of 151.5 USD and a high forecast of 273 USD.
What is Biogen Inc's Revenue forecast?
Projected CAGR
-1%
For the last 14 years the
compound annual growth rate for
Biogen Inc's revenue is
5%.
The projected
CAGR
for the next 3 years is
-1%.
What is Biogen Inc's Operating Income forecast?
Projected CAGR
3%
For the last 14 years the
compound annual growth rate for
Biogen Inc's operating income is
2%.
The projected
CAGR
for the next 3 years is
3%.
What is Biogen Inc's Net Income forecast?
Projected CAGR
26%
For the last 14 years the
compound annual growth rate for
Biogen Inc's net income is
0%.
The projected
CAGR
for the next 3 years is
26%.
